Spero Therapeutics, Inc.SPRONASDAQ
Loading
Current Ratio Over TimeCompressed
Percentile Rank22
3Y CAGR-36.3%
5Y CAGR-9.4%
Year-over-Year Change
Current ratio (current assets / current liabilities)
3Y CAGR
-36.3%/yr
vs -5.7%/yr prior
5Y CAGR
-9.4%/yr
Recent deceleration
Acceleration
-30.6pp
Decelerating
Percentile
P22
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.19 | -38.1% |
| 2023 | 3.53 | -29.9% |
| 2022 | 5.04 | -40.4% |
| 2021 | 8.46 | -12.8% |
| 2020 | 9.70 | +171.1% |
| 2019 | 3.58 | -61.8% |
| 2018 | 9.37 | -12.4% |
| 2017 | 10.70 | +523.6% |
| 2016 | 1.72 | +84.0% |
| 2015 | 0.93 | - |